Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
about
Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.Thymineless Death by the Fluoropyrimidine Polymer F10 Involves Replication Fork Collapse and Is Enhanced by Chk1 Inhibition
P2860
Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeting a non-oncogene addic ...... ent of small cell lung cancer.
@en
Targeting a non-oncogene addic ...... ent of small cell lung cancer.
@nl
type
label
Targeting a non-oncogene addic ...... ent of small cell lung cancer.
@en
Targeting a non-oncogene addic ...... ent of small cell lung cancer.
@nl
prefLabel
Targeting a non-oncogene addic ...... ent of small cell lung cancer.
@en
Targeting a non-oncogene addic ...... ent of small cell lung cancer.
@nl
P2093
P2860
P1433
P1476
Targeting a non-oncogene addic ...... ent of small cell lung cancer.
@en
P2093
Anna Schmitt
Fabian Doerr
Filippo Beleggia
H Christian Reinhardt
Jean-Philip Weber
Julie George
Maike Wittersheim
Reinhard Büttner
Roman K Thomas
Sarah Hermann
P2860
P2888
P356
10.1038/S41598-017-15840-5
P407
P50
P577
2017-11-14T00:00:00Z